Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson's disease biomarkers using multiplexed single molecule counting
Priscilla Youssef, Laura P. Hughes, Woojin S. Kim, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 16

Showing 16 citing articles:

Neuroimaging and fluid biomarkers in Parkinson’s disease in an era of targeted interventions
Angeliki Zarkali, George E. Thomas, Henrik Zetterberg, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 14
The neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, and neutrophil-to-high-density-lipoprotein ratio are correlated with the severity of Parkinson’s disease
Fangyi Li, Guomei Weng, Hang Zhou, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 10
Open-label evaluation of oral trehalose in patients with neuronal ceroid lipofuscinoses
Stefania Della Vecchia, Nicola Gammaldi, Ivana Ricca, et al.
Journal of Neurology (2025) Vol. 272, Iss. 1
Closed Access | Times Cited: 1
Early‐Life Adversity Predicts Markers of Aging‐Related Neuroinflammation, Neurodegeneration, and Cognitive Impairment in Women
Lara Fleck, Claudia Buß, M. Bauer, et al.
Annals of Neurology (2025)
Open Access | Times Cited: 1
Molecular biomarkers of glial activation and injury in epilepsy
Reema A Kalsariya, Dave Kavila, Susan Shorter, et al.
Drug Discovery Today (2025), pp. 104289-104289
Open Access | Times Cited: 1
Alpha-Synuclein in Peripheral Tissues as a Possible Marker for Neurological Diseases and Other Medical Conditions
Félix Javier Jiménez‐Jiménez, Hortensia Alonso‐Navarro, Elena García‐Martín, et al.
Biomolecules (2023) Vol. 13, Iss. 8, pp. 1263-1263
Open Access | Times Cited: 14
Neurofilament light chain as a biomarker for neurodegenerative changes in COVID-19 and clinical implications
Yousef Rasmi, Yeganeh Farnamian, Marijana Marković Boras, et al.
Future Virology (2025), pp. 1-15
Closed Access
Parkinson’s Disease: Biomarkers for Diagnosis and Disease Progression
Rakesh Arya, A. K. M. Ariful Haque, Hemlata Shakya, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12379-12379
Open Access | Times Cited: 4
Future is now: an Australasian perspective on disease-modifying trials in Parkinson’s and prodromal disease
Simon J.G. Lewis, Carolyn M. Sue, Antony A. Cooper, et al.
BMJ Neurology Open (2025) Vol. 7, Iss. 1, pp. e001070-e001070
Open Access
Biomarkers of Parkinson's disease in perspective of early diagnosis and translation of neurotrophic therapies
Raimo K. Tuominen, Juho‐Matti Renko
Basic & Clinical Pharmacology & Toxicology (2024) Vol. 135, Iss. 3, pp. 271-284
Open Access | Times Cited: 3
Moderate intensity aerobic exercise alleviates motor deficits in 6-OHDA lesioned rats and reduces serum levels of biomarkers of Parkinson's disease severity without recovery of striatal dopamine or tyrosine hydroxylase
Ella A. Kasanga, Isabel Soto, Ashley Centner, et al.
Experimental Neurology (2024) Vol. 379, pp. 114875-114875
Open Access | Times Cited: 1
Serum Tau Species in Progressive Supranuclear Palsy: A Pilot Study
Costanza Maria Cristiani, Luana Scaramuzzino, Elvira Immacolata Parrotta, et al.
Diagnostics (2024) Vol. 14, Iss. 23, pp. 2746-2746
Open Access | Times Cited: 1
Machine Learning for Early Detection of Cognitive Decline in Parkinson’s Disease Using Multimodal Biomarker and Clinical Data
Raziyeh Mohammadi, Samuel Yong‐Ern Ng, Jayne Yi Tan, et al.
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2758-2758
Open Access
Significance of neurodegeneration and neuroplasticity serum biomarkers in Parkinson’s disease patients treated with subthalamic stimulation
Florencia Sanmartino, Fátima Cano-Cano, Raúl Rashid-López, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access
Moderate intensity aerobic exercise in 6-OHDA-lesioned rats alleviates established motor deficits and reduces neurofilament light and glial fibrillary acidic protein serum levels without increased striatal dopamine or tyrosine hydroxylase protein
Ella A. Kasanga, Isabel Soto, Ashley Centner, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Biomarkers of Parkinson's disease in perspective of early diagnosis and translation of neurotrophic therapies
Juho‐Matti Renko, Raimo K. Tuominen
Authorea (Authorea) (2023)
Open Access
Page 1

Scroll to top